Skip to main content
Caplight Logo









Hangzhou Calibra Diagnostics Co., Ltd.

Hangzhou Calibra Diagnostics Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://calibradx.com/

Last Round

Series C

Extension

Dec 27, 2022

Total Funding Raised

$65.08M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hangzhou Calibra Diagnostics Co., Ltd. is a biotechnology company that provides clinical mass spectrometry solutions, reagents, consumables, and laboratory services for precision medicine and multi-omics research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

mass spectrometrymetabolomicsclinical diagnosticsprecision medicineliquid chromatography tandem mass spectrometryLC-MS/MSmulti-omicsbiomarker discoverypharma CROcontract research organizationdiagnostic reagentsclinical lab serviceslab automationlab quality controlomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Calibra Diagnostics Co., Ltd. Comparables

Compare Hangzhou Calibra Diagnostics Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Calibra Diagnostics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shandong Yingsheng Biotechnology Co., Ltd.
87%
Hangzhou Well-healthcare Technologies Co., Ltd.
86%
Shanghai Reigncom Biotech Co., Ltd.
85%

Hangzhou Calibra Diagnostics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 27, 2022
Series CMay 5, 2022
Series BFeb 24, 2021
Series ASep 1, 2020
AngelDec 1, 2016

Key People

Founding team and executive leadership

Huafen Liu

Founder and CEO

Founding Team

Hangzhou Calibra Diagnostics Co., Ltd. Investors

Notable investors and investment history

Hangzhou Calibra Diagnostics Co., Ltd. investors
InvestorRounds
Boyuan CapitalSeries A
Delian CapitalSeries B
松禾资本 (Green Pine Capital Partners)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 521% MoM, reaching 6.1K.

  • Dec 27, 2022

    Raised $4.29M in Series C Extension funding.

Hangzhou Calibra Diagnostics Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hangzhou Calibra Diagnostics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hangzhou Calibra Diagnostics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range6
Year Founded2016
Last FundingDec 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?